MedPath

Samsung Medical Center

Samsung Medical Center logo
🇰🇷South Korea
Ownership
Subsidiary
Established
1994-01-01
Employees
501
Market Cap
-
Website
http://www.samsunghospital.com

Predict Antidepressant Responsiveness Using Pharmacogenomics

Not Applicable
Conditions
Depressive Symptoms
Depression
Interventions
Drug: SSRI treated group
Drug: non-SSRI treated group
First Posted Date
2010-10-26
Last Posted Date
2015-12-31
Lead Sponsor
Samsung Medical Center
Target Recruit Count
1000
Registration Number
NCT01228357
Locations
🇰🇷

Samsung Medical Center, Kangnam, Seoul, Korea, Republic of

Multicenter Retrospective Analysis About the Clinical Characteristics of Korean Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

Conditions
Hemoglobinuria, Paroxysmal
First Posted Date
2010-10-20
Last Posted Date
2010-10-20
Lead Sponsor
Samsung Medical Center
Target Recruit Count
350
Registration Number
NCT01224483
Locations
🇰🇷

Division of Hematology Oncology, Samsung Medical Center, Seoul, Korea, Republic of

Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME)

Phase 1
Completed
Conditions
Diabetic Retinopathy
Macular Edema
First Posted Date
2010-09-15
Last Posted Date
2010-09-15
Lead Sponsor
Samsung Medical Center
Target Recruit Count
41
Registration Number
NCT01202461
Locations
🇰🇷

Samsung Medical Center, Seoul, S. Korea, Korea, Republic of

Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma

Not Applicable
Completed
Conditions
Diffuse Large B-cell Lymphoma
Interventions
Procedure: CSF analysis
First Posted Date
2010-09-15
Last Posted Date
2015-03-03
Lead Sponsor
Samsung Medical Center
Target Recruit Count
600
Registration Number
NCT01202448
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Repetitive Transcranial Magnetic Stimulation(rTMS) in the Treatment of Depression

Conditions
Major Depressive Disorder
Interventions
Device: repetitive Transcranial Magnetic Stimulation
First Posted Date
2010-09-10
Last Posted Date
2015-12-31
Lead Sponsor
Samsung Medical Center
Target Recruit Count
40
Registration Number
NCT01198561
Locations
🇰🇷

Samsung Medical Center, Seoul, Kangnam-Ku, Korea, Republic of

RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas

Phase 1
Completed
Conditions
Anaplastic Large Cell Lymphoma, ALK-negative
Peripheral T Cell Lymphoma Unspecified
Angioimmunoblastic T Cell Lymphoma
Cutaneous T Cell Lymphoma
Interventions
Drug: RAD001 (Everolimus)
First Posted Date
2010-09-10
Last Posted Date
2015-03-03
Lead Sponsor
Samsung Medical Center
Target Recruit Count
46
Registration Number
NCT01198665
Locations
🇰🇷

National Cancer Center, Goyang-si, Kyoungki-do, Korea, Republic of

🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

and more 2 locations

Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD)

Conditions
Alzheimer's Disease
First Posted Date
2010-09-09
Last Posted Date
2012-09-28
Lead Sponsor
Samsung Medical Center
Target Recruit Count
800
Registration Number
NCT01198093
Locations
🇰🇷

Samsung Medical Center, Seoul, Kangnam-Ku, Korea, Republic of

The Use of Ultrasonic Coagulating Shears Compared to Monopolar Electrocautery in Open Gastric Cancer Surgery

Phase 3
Conditions
Stomach Cancer
Gastrectomy
Ultrasonic Coagulating Shears
Interventions
Device: Ultrasonic Coagulating Shears
First Posted Date
2010-08-11
Last Posted Date
2010-12-16
Lead Sponsor
Samsung Medical Center
Target Recruit Count
256
Registration Number
NCT01179750
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Diagnostic Utility of Pleural Fluid MAGE Assay in Patients With Pleural Effusion From Primary Lung Cancer

Not Applicable
Completed
Conditions
Unilatral Pleural Effusion
First Posted Date
2010-08-11
Last Posted Date
2011-07-21
Lead Sponsor
Samsung Medical Center
Target Recruit Count
100
Registration Number
NCT01179685
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial

Not Applicable
Conditions
Delayed Bleeding
Interventions
Drug: high dose proton pump inhibitor
Drug: H2RB
First Posted Date
2010-08-11
Last Posted Date
2010-08-11
Lead Sponsor
Samsung Medical Center
Target Recruit Count
206
Registration Number
NCT01179724
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath